deltatrials
Terminated NA INTERVENTIONAL 2-arm NCT01363557

Assess the Efficacy of Whole Brain Radiation Therapy in Lung Cancer Patients With Brain Metastasis (ARPEGE)

Randomized to Assess the Efficacy of Whole Brain Radiation Therapy (WBRT) With Concomitant Gefitinib Followed by Maintenance Gefitinib, and Gefitinib Alone, in Lung Cancer Patients With Brain Metastasis

Sponsor: Assistance Publique - Hôpitaux de Paris

Conditions Brain Metastasis EGFR-mutated Lung Adenocarcinoma
Interventions Gefitinib (IRESSA) whole brain radiotherapy
Updated 5 times since 2017 Last updated: May 12, 2014 Started: Mar 31, 2012 Primary completion: Aug 31, 2012 Completion: May 31, 2013
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Decision of Sponsor

Other terminated trials from Assistance Publique - Hôpitaux de Paris

See all terminations from Assistance Publique - Hôpitaux de Paris

Other Brain Metastasis trials with similar outcome

Browse all Brain Metastasis trials

This NA trial investigates Brain Metastasis and EGFR-mutated Lung Adenocarcinoma and is currently terminated or withdrawn. Assistance Publique - Hôpitaux de Paris leads this study, which shows 5 recorded versions since 2012 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 24 months · monthly snapshotTerminated

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated NA

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated NA

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated NA

  4. Jun 2018 — Jan 2021 [monthly]

    Terminated NA

  5. Jan 2017 — Jun 2018 [monthly]

    Terminated NA

    First recorded

Mar 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Assistance Publique - Hôpitaux de Paris
  • Ministry of Health, France
Data source: Assistance Publique - Hôpitaux de Paris

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations